Results 101 to 110 of about 4,771 (191)

Augmented epigenetic repression of hepatitis B virus covalently closed circular DNA by interferon-α and small-interfering RNA synergy

open access: yesmBio
The persistence of hepatitis B virus (HBV) covalently closed circular DNA (cccDNA) is a key obstacle for HBV cure. This study aims to comprehensively assess the effect of interferon (IFN) and small-interfering RNA (siRNA) combination on the cccDNA ...
Kongying Hu   +10 more
doaj   +1 more source

Potential role of G-protein coupled receptors in mediating Belinostat induced activation of the Hippo pathway.

open access: yes, 2013
Panel A. Effect of conditioned medium from Belinostat pre-exposed cells on activation of the Hippo reporter in naïve cells (not previously exposed to the drug).
Miguel Reyes-Múgica (5654968)   +2 more
core   +1 more source

Real-World Outcomes of Belinostat in Relapsed Refractory T-Cell Lymphomas: A Report from the Lymphoma Study Group of Turkish Society of Hematology. [PDF]

open access: yesJ Clin Med
Ulukoylu Menguc M   +39 more
europepmc   +1 more source

A Six-year Response to Belinostat in a Highly Probable Case of Relapsed/Refractory MF/SS Initially Classified as PTCL-NOS: A Case Report. [PDF]

open access: yesOnco Targets Ther
Gauthier N   +6 more
europepmc   +1 more source

Screening and evaluation of potential histone deacetylase inhibitors against Babesia infections. [PDF]

open access: yesInt J Parasitol Drugs Drug Resist
Zhang X   +10 more
europepmc   +1 more source

Cancer-associated KBTBD4 mutations induce differentiation defects and confer a unique therapeutic vulnerability. [PDF]

open access: yesCancer Gene Ther
Sivaprasad R   +8 more
europepmc   +1 more source

Correction: Glucuronidation by UGT1A1 Is the Dominant Pathway of the Metabolic Disposition of Belinostat in Liver Cancer Patients

open access: yesPLoS ONE, 2014
Ling-Zhi Wang   +16 more
doaj   +3 more sources

Home - About - Disclaimer - Privacy